ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: Different researches have shown that ANGPTL8 concentrations were altered in diseases such as obesity, diabetes mellitus, metabolic syndrome [2] and non-alcoholic fatty liver disease (NAFLD) [6].